Gastroenterology and Hepatology from Bed to Bench

Miranda MJ, Turner Z, Magrath G. Alternative diets to the classical ketogenic diet-Can we be more liberal?. Epilepsy Res 2012;100:278–285.

Wheless JW. History of the ketogenic diet. Epilepsia 2008;49:3–5.

Branco AF, Ferreira A, Simões RF, Magalhães-Novais S, Zehowski C, Cope E, et al. Ketogenic diets: From cancer to mitochondrial diseases and beyond. Eur J Clin Invest 2016;46:285–298.

Kalra S, Singla R, Rosha R, Dhawan M. Ketogenic diet: Situational analysis of current nutrition guidelines. J Pak Med Ass 2018;68, pp. 1836–1839.

Bolla AM, Caretto A, Laurenzi A, Scavini M, Piemonti L. Low-carb and ketogenic diets in type 1 and type 2 diabetes, Nutrients 2019;11:962.

Gregory RM, Hamdan H, Torisky DM, Akers JD. A low-carbohydrate ketogenic diet combined with 6-weeks of crossfit training improves body composition and performance. Int J Sports Ex Med 2017;3:054.

Paoli A, Mancin L, Thomas E, Mota JF, Piccini F. Ketogenic diet and microbiota: Friends or enemies?. Genes 2019;10:534.

Mills S, Stanton C, Lane JA, Smith GJ, Ross RP. Precision nutrition and the microbiome, part I: Current state of the science. Nutrients 2019;11:1–45.

Reddel S, Putignani L, Del Chierico F. The impact of low-FODMAPs, gluten-free, and ketogenic diets on gut microbiota modulation in pathological conditions. Nutrients 2019;11:373.

Dowis K, Banga S. The potential health benefits of the ketogenic diet: a narrative review. Nutrients 2021;13:1654.

Attaye I, van Oppenraaij S, Warmbrunn MV, Nieuwdorp M. The role of the gut microbiota on the beneficial effects of ketogenic diets. Nutrients 2022;14:191.

Zhu H, Bi D, Zhang Y, Kong C, Du J, Wu X, et al. Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations. Signal Transduct Target Ther 2022;7:11.

Nguyen TLA, Vieira-Silva S, Liston A, Raes J. How informative is the mouse for human gut microbiota research?. Dis Models Mech 2015;8:1–16.

Yatsunenko T, Rey F, Manary M, Trehan I, Dominguez-Bello M., Contreras M, et al. Human gut microbiome viewed across age and geography. Nature 2012;486:222–227.

Rodríguez JM, Murphy K, Stanton C, Ross RP, Kober OI, Juge N, et al. The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Health Dis 2015;26:26050.

Krebs HA. The regulation of the release of ketone bodies by the liver. Adv Enzyme Reg 1966;4:339–354.

Cahill GF. Fuel Metabolism in Starvation. Annu Rev Nutr 2006;26:1–22.

El Bacha T, Luz M, Da Poian A. Dynamic Adaptation of Nutrient Utilization in Humans. Nat Educ 2010;3:8.

Clifton P, Brouns F. Low-carbohydrate diets: Nutritional and physiological aspects. Obes Rev 2006;7:49–58.

Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes/Metab Res Rev 1999;15:412–426.

Liu YM, Wang HS. Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy and a comparison with other ketogenic diets. Biomed J 2013;36:9–15.

Westman EC, Feinman RD, Mavropoulos JC, Vernon MC, Volek JS, Wortman JA, et al. Low-carbohydrate nutrition and metabolism. Am J Clin Nutr 2007;86:276–284.

Paoli A. Ketogenic diet for obesity: Friend or foe?. Int J Environ Res Public Health. 2014;11:2092–2107.

Guerci B, Benichou M, Floriot M, Bohme P, Fougnot S, Franck P, et al. Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients. Diabetes Care 2003;26:1137–1141.

Volek JS, Phinney SD. The art and science of low carbohydrate living. 2011; 1st edn. Lexington: Beyond Obesity LLC.

Harvey CJDC, Schofield GM, Williden M. The use of nutritional supplements to induce ketosis and reduce symptoms associated with keto-induction: a narrative review. Peer J 2018;6:4488.

Schoeler NE, Cross JH. Ketogenic dietary therapies in adults with epilepsy: a practical guide. Pract Neurol 2016;1:208–214.

Tagliabue A, Ferraris C, Uggeri F, Trentani C, Bertoli S, de Giorgis V, et al. Short-term impact of a classical ketogenic diet on gut microbiota in GLUT1 Deficiency Syndrome: a 3-month prospective observational study. Clin Nutr ESPEN 2017;17:33–37.

Westerterp-Plantenga MS, Lemmens SG, Westerterp KR. Dietary protein - Its role in satiety, energetics, weight loss and health. Br J Nutr 2012;108:105–112.

Marchesi JR, Ravel J. The vocabulary of microbiome research: A proposal. Microbiome 2015;3:31.

Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLOS Biol 2016;14:1002533.

Tap J, Mondot S, Levenez F, Pelletier E, Caron C, Furet JP, et al. Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 2009;11:2574–2584.

Lozupone C, Stomabaugh J, Gordon J, Jansson J, Knight R. Diversity , stability and resilience of the human gut microbiota. Nature 2012;489:220–230.

Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. Enterotypes of the human gut microbiome’, Nature 2011;473:174–180.

Faith JJ, Guruge JL, Charbonneau M, Subramanian S, Seedorf H, Goodman AL, et al. The long-term stability of the human gut microbiota. Science 2013;341:1–22.

Rajilić-Stojanović M, Heilig HGHJ, Tims S, Zoetendal EG, De Vos WM. Long-term monitoring of the human intestinal microbiota composition. Environ Microbiol 2013;15:1146–1159.

Mueller S, Saunier K, Hanisch C, Norin E, Alm L, Midtvedt T, et al. Differences in faecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 2006;72:1027–1033.

Kim YS, Unno T, Kim BY, Park MS, et al. Sex differences in gut microbiota. World J Men’s Health 2019;37:1–13.

Karl PJ, Hatch AM, Arcidiacono SM, Pearce SC, Pantoja-Feliciano IG, Doherty LA, et al. Effects of psychological, environmental and physical stressors on the gut microbiota. Front Microbiol 2018;9:1–32.

Iizumi T, Battaglia T, Ruiz V, Perez Perez GI. Gut microbiome and antibiotics. Arch Med Res 2017;48:727–734.

Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 2018;555:623–628.

Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, Ze X, et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J 2011;5:220–230.

Conlon MA, Bird AR. The impact of diet and lifestyle on gut microbiota and human health. Nutrients 2015;7:17–44.

Oliphant K, Allen-Vercoe E. Macronutrient metabolism by the human gut microbiome: Major fermentation by-products and their impact on host health. Microbiome 2019;7:91.

Kho ZY, Lal SK. The human gut microbiome - a potential controller of wellness and disease. Front Microbiol 2018;9:1835.

Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From dietary fibre to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 2016;165:1332–1345.

Singh RK, Chang HW, Yan D, Lee KM, Ucmak D, Wong K, et al. Influence of diet on the gut microbiome and implications for human health. J Transl Med 2017;15:73.

Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 2016;7:189–200.

Lin L, Zhang J. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. BMC Immunol 2017;18:1–25.

Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E. Dysbiosis and the immune system. Nat Rev Immunol 2017;17:219–232.

Marchesi JR, Adams DH, Fava F, Hermes GDA, Hirschfield GM., Hold G, et al. The gut microbiota and host health: a new clinical frontier. Gut 2016;65:330–339.

Graf D, Di Cagno R, Fåk F, Flint HJ, Nyman M, Saarela M, et al. Contribution of diet to the composition of the human gut microbiota. Microb Ecol Health Dis 2015;26:26164.

Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011;334:105–108.

David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014;505:559–563.

Klimenko NS, Tyakht AV, Popenko AS, Vasiliev AS, Altukhov IA, Ischenko DS, et al. Microbiome responses to an uncontrolled short-term diet intervention in the frame of the citizen science project. Nutrients 2018;10:576.

Portune KJ, Benítez-Páez A, Del Pulgar EMG, Cerrudo V, Sanz Y. Gut microbiota, diet, and obesity-related disorders—The good, the bad, and the future challenges. Mole Nutr and Food Res 2017;61:1–17.

Chen HM, Yu YN, Wang JL, Lin YW, Kong X, Yang CQ, et al. Decreased dietary fibre intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma. Am J Clin Nutr 2013;97:1044–1052.

Scott KP, Gratz SW, Sheridan PO, Flint HJ, Duncan SH. The influence of diet on the gut microbiota. Pharmacol Res 2013;69:52–60.

Morales P, Fujio S, Navarrete P, Ugalde JA, Magne F, Carrasco-Pozo C, et al. Impact of dietary lipids on colonic function and microbiota: an experimental approach involving orlistat-induced fat malabsorption in human volunteers. Clin Transl Gastroenterol 2016;7:161.

Huang CB, George B, Ebersole JL. Antimicrobial activity of n-6, n-7 and n-9 fatty acids and their esters for oral microorganisms. Arch Oral Biol 2010;55:555–560.

Cândido FG, Valente FX, Grześkowiak ŁM, Moreira APB, Rocha DMUP, Alfenas RCG. Impact of dietary fat on gut microbiota and low-grade systemic inflammation: Mechanisms and clinical implications on obesity. Int J Food Sci Nutr 2018;69:125–143.

Yao CK, Muir JG, Gibson PR Review article: insights into colonic protein fermentation, its modulation and potential health implications. Aliment Pharmacolt Ther 2016;43:181–196.

Blachier F, Beaumont M, Portune KJ, Steuer N, Lan A, Audebert M, et al. High-protein diets for weight management: interactions with the intestinal microbiota and consequences for gut health. A position paper by the my new gut study group. Clin Nutr 2019; 38:1012–1022.

Centre for Reviews and Dissemination Systematic Reviews CRD’s guidance for undertaking reviews in health care. York: Centre for Reviews and Dissemination, University of York; 2009; Available at: https://www.york.ac.uk/media/crd/Systematic_Reviews.pdf .

Coughlan M, Cronin P. Doing a literature review in nursing, health and social care. 2nd edn. London: SAGE 2013.

Gough D, Oliver S, Thomas J. An introduction to systematic reviews. 2nd edn. London: SAGE 2017.

Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:1000097.

National Institute of Care and Excellence (NICE) Methods for the development of NICE public health guidance. 2018 Available at: https://www.nice.org.uk/process/pmg4/chapter/introduction.

Aveyard H. Doing a literature review in health and social care: a practical guide. 4th edn. Maidenhead: Open University Press 2019.

Braun V, Clarke V. Successful qualitative research: A practical guide for beginners. 1st edn. London: SAGE 2013.

Higgins JPT, Green S. (eds.) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. 2011. Available at: https://training.cochrane.org/handbook.

Brinkworth GD, Noakes M, Clifton PM, Bird AR. Comparative effects of very low-carbohydrate, high-fat and high-carbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations. Br J Nutr 2009;101:1493–1502.

Duncan SH, Lobley GE, Holtrop G, Ince J, Johnstone AM, Louis P, et al. Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes 2008;32:1720–1724.

Mardinoglu A, Wu H, Bjornson E, Zhang C, Hakkarainen A, Räsänen SM, et al. An integrated understanding of the rapid metabolic benefits of a carbohydrate-restricted diet on hepatic steatosis in humans. Cell Metab 2018;27:559–571.

Murtaza N, Burke LM, Vlahovich N, Charlesson B, O’ Neill H, Ross ML, et al. The effects of dietary pattern during intensified training on stool microbiota of elite race walkers. Nutrients 2019;11:261.

Russell WR, Gratz SW, Duncan SH, Holtrop G, Ince J, Scobbie L, et al. High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am J Clin Nutr 2011;93:1062–1072.

Swidsinski A, Dörffel Y, Loening-Baucke V, Gille C, Göktas Ö, Reißhauer A, et al. Reduced mass and diversity of the colonic microbiome in patients with multiple sclerosis and their improvement with ketogenic diet. Front Microbiol 2017;8:1141.

Gopalakrishnan S, Ganeshkumar P. Systematic reviews and meta-analysis: Understanding the best evidence in primary healthcare. J Family Med Prim Care 2013;2:9-14.

Duncan SH, Belenguer A, Holtrop G, Johnstone AM, Flint HJ, Lobley GE. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol 2007;73:1073–1078.

Newell C, Bomhof MR, Reimer RA, Hittel DS, Rho JM, Shearer J. Ketogenic diet modifies the gut microbiota in a murine model of autism spectrum disorder. Molecular Autism 2016;7:37.

Zhang Y, Zhou S, Zhou Y, Yu L, Zhang L, Wang Y. Altered gut microbiome composition in children with refractory epilepsy after ketogenic diet. Epilepsy Research 2018;145:163–168.

Knudsen KEB, Nørskov NP, Bolvig AK, Hedemann MS, Laerke HN. Dietary fibres and associated phytochemicals in cereals. Mol Nutr Food Res 2017;61:1600518.

Rivière A, Selak M, Lantin D, Leroy F, De Vuyst L. Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol 2016;7:979.

de Vries W, Stouthamer AH. Pathway of glucose fermentation in relation to the taxonomy of Bifidobacteria. J Bacteriol 1967;93:574–576.

De Vuyst L, Moens F, Selak M, Rivière A, Leroy F. Summer Meeting 2013: growth and physiology of Bifidobacteria. J Appl Microbiol 2014;116:477–491.

Puchalska P, Crawford PA. Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics. Cell Metab 2017;25:262–284.

Tognini P, Murakami M, Liu Y, Eckel-Mahan KL, Newman JC, Verdin E, et al. Distinct circadian signatures in liver and gut clocks revealed by ketogenic diet. Cell Metab 2017;26:523-538.

Ang QY, Alexander M, Newman JC, Tian Y, Cai J, Upadhyay V, et al. Ketogenic diets alter the gut microbiome resulting in decreased intestinal Th17 cells. Cell 2020;181:1263-1275.

Baxter NT, Schmidt AW, Venkataraman A, Kim KS, Waldron C, Schmidt TM. Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibres. mBio 2019;10:02566-18.

Simpson HL, Campbell BJ. Review article: dietary fibre-microbiota interactions. Aliment Pharmacol Ther 2015;42:158–179.

Duncan SH, Louis P, Thomson JM, Flint HJ. The role of pH in determining the species composition of the human colonic microbiota. Environ Microbiol 2009;11:2112–2122.

Holscher HD. Dietary fibre and prebiotics and the gastrointestinal microbiota. Gut Microbes 2017;8:172–184.

Russell DA, Ross RP, Fitzgerald GF, Stanton C. Metabolic activities and probiotic potential of Bifidobacteria. Int J Food Microbiol 2011;149:88–105.

van der Beek CM, Dejong CHC, Troost FJ, Masclee AAM, Lenaerts K. Role of short-chain fatty acids in colonic inflammation, carcinogenesis, and mucosal protection and healing. Nutr Rev 2017;75:286–305.

Peng L, Li ZR, Green RS, Holzman IR, Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr 2009;139:1619–1625.

Jung TH, Park JH, Jeon WM, Han KS. Butyrate modulates bacterial adherence on LS174T human colorectal cells by stimulating mucin secretion and MAPK signaling pathway. Nutr Res Pract 2015;9:343–349.

Corrêa-Oliveira R, Fachi JL, Vieira A, Sato FT, Vinolo MAR. Regulation of immune cell function by short-chain fatty acids. Clin Transl Immunol 2016;5:73.

Ríos-Covián D, Ruas-Madiedo P, Margolles A, Gueimonde M, De los Reyes-Gavilán CG, Salazar N. Intestinal short chain fatty acids and their link with diet and human health. Front Microbiol 2016;7:185.

Huda-Faujan N, Abdulamir AS, Fatimah AB, Anas OM, Shuhaimi M, Yazid AM, et al. The impact of the level of the intestinal short chain fatty acids in inflammatory bowel disease patients versus healthy subjects. Open Biochem J 2010:4:53–58.

Kumari R, Ahuja V, Paul J. Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India World J Gastroenterol 2013;19:3404–3414.

Owczarek D, Rodacki T, Domagała-Rodacka R, Cibor D, Mach T. Diet and nutritional factors in inflammatory bowel diseases. World J Gastroenterol 2016;22:895–905.

Rapozo DCM, Bernardazzi C, De Souza HSP. Diet and microbiota in inflammatory bowel disease: the gut in disharmony. World J Gastroenterol 2017;23:2124–2140.

Yang J, Yu J. The association of diet, gut microbiota and colorectal cancer: what we eat may imply what we get. Protein Cell 2018;9:474–487.

Matsuoka K, Kanai T. The gut microbiota and inflammatory bowel disease. Semin Immunopathol 2015;37:47–55.

Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 2012;6:320–329.

Bottacini F, Ventura M, van Sinderen D, Motherway MOC. Diversity, ecology and intestinal function of bifidobacteria. Microbial Cell Factories 2014;13:4.

Ling X, Linglong P, Weixia D, Hong W. Protective effects of Bifidobacterium on intestinal barrier function in LPS-induced enterocyte barrier injury of Caco-2 monolayers and in a rat NEC model. PLoS ONE 2016;11:0161635.

O’Callaghan A, van Sinderen D. Bifidobacteria and their role as members of the human gut microbiota. Front Microbiol 2016;7:925.

Coakley M, Ross RP, Nordgren M, Fitzgerald G, Devery R, Stanton C. Conjugated linoleic acid biosynthesis by human-derived Bifidobacterium species. J Appl Microbiol 2003;94:138–145.

Le Leu RK, Hu Y, Brown IL, Woodman RJ, Young GP. Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis 2010;31:246–251.

Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy. Science 2015;350:1084–1089.

Borges-Canha M, Portela-Cidade JP, Dinis-Ribeiro M, Leite-Moreira AF, Pimentel-Nunes P. Role of colonic microbiota in colorectal carcinogenesis: a systematic review. Rev Esp Enferm Dig 2015;107:659–671.

Gianfredi V, Salvatori T, Villarini M, Moretti M, Nucci D, Realdon S. Is dietary fibre truly protective against colon cancer? a systematic review and meta-analysis. Int J Food Sci Nutr 2018;69:904–915.

Yao Y, Suo T, Andersson R, Cao Y, Wang C, Lu J, et al. Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas. Cochrane Database Syst Rev 2017;1:003430.

Sze MA, Topçuoğlu BD, Lesniak NA, Ruffin MT, Schloss PD. Faecal short-chain fatty acids are not predictive of colonic tumor status and cannot be predicted based on bacterial community structure. mBio 2019;10:01454-19.

Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol,2011;106:563–573.

Wong C, Harris PJ, Ferguson LR. Potential benefits of dietary fibre intervention in inflammatory bowel disease. Int J Mol Sci 2016;17:919.

Rahman M, Muhammad S, Khan MA, Chen H, Ridder DA, Müller-Fielitz H, et al. The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages. Nat Commun 2014;5:3944.

Stilling RM, van de Wouw M, Clarke G, Stanton C, Dinan TG, Cryan JF. The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis?. Neurochem Int 2016;99:110–132.

Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, et al. Supression of oxidative stress and β-OHB as endogenous histone deactetylase. Science 2013;339:211–214.

Newman JC, Verdin E. β-hydroxybutyrate: Much more than a metabolite. Diabetes Res Clin Pract 2014;106:173–181.

Klement RJ, Pazienza V. Impact of different types of diet on gut microbiota profiles and cancer prevention and treatment. Medicina 2019;55:84.

Arboleya S, Watkins C, Stanton C, Ross RP. Gut bifidobacteria populations in human health and aging. Front Microbiol 2016;7:1204.

Furet JP, Kong LC, Tap J, Poitou C, Basdevant A, Bouillot JL, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 2010;59:3049–3057.

Wu X, Ma C, Han L, Nawaz M, Gao F, Zhang X, et al. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr Microbiol 2010;61:69–78.

Million M, Angelakis E, Maraninchi M, Henry M, Giorgi R, Valero R, et al. Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli. Int J Obes 2013;37:1460–1466.

Gao X, Jia R, Xie L, Kuang L, Feng L, Wan C. Obesity in school-aged children and its correlation with Gut E.coli and Bifidobacteria: a case-control study. BMC Pediatr 2015;15:64.

Aizawa E, Tsuji H, Asahara T, Takahashi T, Teraishi T, Yoshida S, et al. Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder. J Affect Disord 2016;202:254–257.

Tseng CH, Wu CY. The gut microbiome in obesity. J Formos Med Assoc 2019;118:3–9.

Xiong Y, Miyamoto N, Shibata K, Valasek MA, Motoike T, Kedzierski RM, et al. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc Nat Acad Sci U S 2004;101:1045–1050.

Cohen MM. Role of leptin in regulating appetite, neuroendocrine function, and bone remodeling. Am J Med Genet 2006;140:515–524.

Samuel BS, Shaito A, Motoike T, Rey FE, Backhed F, Manchester JK, et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Nat Acad Sci U S 2008;105:167616772.

Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 2012;61:364–371.

D’Alessio D. Intestinal hormones and regulation of satiety: the case for CCK, GLP-1, PYY, and Apo A-IV. J Parent Enter Nutr 2008;32:567–568.

Den Besten G, Van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lip Res 2013;54:2325–2340.

Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007;56:1761–1772.

Cani PD, Bibiloni R, Knauf C, Neyrinck AM, Delzenne NM. Changes in gut microbiota control metabolic diet–induced obesity and diabetes in mice. Diabetes 2008;57:1470–1481.

Lyte JM, Gabler NK, Hollis JH. Postprandial serum endotoxin in healthy humans is modulated by dietary fat in a randomized, controlled, cross-over study. Lipids Health Dis 2016;15:186.

Mehta NN, McGillicuddy FC, Anderson PD, Hinkle CC, Shah R, Pruscino L, et al. Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes 2010;59:172–181.

Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, Alessi MC, et al. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 2008;87:1219–1223.

Maes M, Kubera M, Leunis JC, Berk M. Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut. J Affect Disord 2012;141:55–62.

Fuke N, Nagata N, Suganuma H, Ota T. Regulation of gut microbiota and metabolic endotoxemia with dietary factors. Nutrients 2019;11:2277.

Wang J, Tang H, Zhang C, Zhao Y, Derrien M, Rocher E, et al. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J 2015;9:1–15.

Mazloom K, Siddiqi I, Covasa M. Probiotics: How effective are they in the fight against obesity?. Nutrients 2019;11:1–24.

Tan TG, Sefik E, Geva-Zatorsky N, Kua L, Naskar D, Teng F, et al. Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice. Proc Natl Acad Sci U S A 2016;113:8141–8150.

Flux MC, Lowry CA. Finding intestinal fortitude: Integrating the microbiome into a holistic view of depression mechanisms, treatment, and resilience. Neurobiol Dis 2020;135:104578.

Scriven M, Dinan T, Cryan J, Wall M, et al. Neuropsychiatric disorders: Influence of gut microbe to brain signalling. Diseases 2018;6:78.

Bonaz B, Bazin T, Pellissier S. The vagus nerve at the interface of the microbiota-gut-brain axis. Front Neurosci 2018;12:49.

Duman RS, Sanacora G, Krystal JH. Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron 2019;102:75–90.

Barrett E, Ross RP, O’Toole PW, Fitzgerald GF, Stanton C. γ-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol 2012;113:411–417.

Boonstra E, de Kleijn R, Colzato LS, Alkemade A, Forstmann BU, Nieuwenhuis S. Neurotransmitters as food supplements: The effects of GABA on brain and behavior. Front Psychol 2015;6:1520.

Johnson KVA, Foster KR. Why does the microbiome affect behaviour?. Nat Rev Microbiol 2018;16:647–655.

Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X, et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. J Neurogastroenterol Motil 2011;23:1132–1139.

Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG. The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res 2008;43:164–174.

Pinto-Sanchez MI, Hall GB, Ghajar K, Nardelli A, Bolino C, Lau JT, et al. Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with Irritable Bowel Syndrome. Gastroenterol 2017;153:448–459.

la Rosa PS, Brooks JP, Deych E, Boone EL, Edwards DJ, Wang Q, et al. Hypothesis testing and power calculations for taxonomic-based human microbiome data. PLoS ONE 2012;7:52078.

Kelly BJ, Gross R, Bittinger K, Sherrill-Mix S, Lewis JD, Collman R, et al. Power and sample-size estimation for microbiome studies using pairwise distances and PERMANOVA. Bioinformatics 2015;31:2461–2468.

Debelius J, Song SJ, Vazquez-Baeza Y, Xu ZZ, Gonzalez A, Knight R. Tiny microbes, enormous impacts: What matters in gut microbiome studies?. Genome Biol 2016;17:217.

Staley C, Kaiser T, Khoruts A. Clinician guide to microbiome testing. Dig Dis Sci Springer US, 2018;63:3167–3177.

Monda V, Villano I, Messina A, Valenzano A, Esposito T, Moscatelli F, et al. Exercise modifies the gut microbiota with positive health effects. Oxid Med and Cell Longev 2017:3831972.

Nettleton JE, Reimer RA, Shearer J. Reshaping the gut microbiota: impact of low calorie sweeteners and the link to insulin resistance?. Physiol Behav 2016;164:488-493.

McFarland LV. Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ Open 2014;4:005047.

Derrien M, van Hylckama Vlieg JE. Fate, activity, and impact of ingested bacteria within the human gut microbiota. Trends Microbiol 2015;23:354–366.